The University of Pennsylvania and Penn Medicine’s annual Penn’s Way campaign concluded on Nov. 24, 2023. Titled “Going the Distance,” the workplace charitable giving drive reached out to the Penn community, and the community responded generously. Reflecting the theme of the campaign, “Going the Distance for Our Community,” Penn and Penn Medicine matched individual contributions 100%.
This year’s pilot Matching Program was highly successfully in raising funds for more than 2,100 charitable organizations. The University and Health System granted staff the autonomy to give to their chosen charities, even adding a feature to recommend organizations to be added to Penn’s Way. The charitable organizations that received the most donations for this year’s campaign include The Jewish Federation, Philabundance, Doctors Without Borders, Bread and Roses Community Fund, and Project Home.
Dollar for dollar, and donor for donor, each and every contribution will help communities and individuals who need it most.
1,400
Number of organizations that received Penn’s Way donations
2,630
Number of first-time donors in this campaign
$2,264,349
Total funds raised this campaign
$2,264,349
Total funds to be matched
$4,528,698
Total funds given to charitable organizations through Penn’s Way this year
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
